Abivax SA Stock Chart

Abivax SA (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Abivax SA

LSE
Market Cap
5.62B
Shares Out.
77.83M
Sector
Health Technology
Industry
Pharmaceuticals: Other

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

www.abivax.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0RA9.GB (0RA9.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart